First Time Loading...

Allena Pharmaceuticals Inc
NASDAQ:ALNA

Watchlist Manager
Allena Pharmaceuticals Inc Logo
Allena Pharmaceuticals Inc
NASDAQ:ALNA
Watchlist
Price: 0.0112 USD -10.4% Market Closed
Updated: May 5, 2024

Allena Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allena Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Allena Pharmaceuticals Inc
NASDAQ:ALNA
Cash from Financing Activities
$41.3m
CAGR 3-Years
N/A
CAGR 5-Years
65%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Allena Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
41.3m USD

Based on the financial report for Dec 31, 2021, Allena Pharmaceuticals Inc's Cash from Financing Activities amounts to 41.3m USD.

What is Allena Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
65%

Over the last year, the Cash from Financing Activities growth was 22%.